Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05038124

A Study of Stereotactic Body Radiotherapy (SBRT) and Surgical Stabilization for People With Cancer That Has Spread to the Bone

A Pilot Study to Assess the Safety and Efficacy of Preoperative Stereotactic Body Radiotherapy for the Treatment of Metastatic Disease in Bone Requiring Surgical Stabilization

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
39 (actual)
Sponsor
Memorial Sloan Kettering Cancer Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to test the safety of stereotactic body radiation therapy (SBRT) followed by surgical stabilization within 1 week. All participants will have metastatic cancer in the bone (bone metastases), and they will be at risk of pathologic fracture (broken bone caused by a disease). Another purpose of this study is to see if the treatment approach of SBRT followed by surgical stabilization within 1 week prevents cancer from returning to the bone.

Conditions

Interventions

TypeNameDescription
RADIATIONPreoperative Stereotactic Body Radiotherapy (SBRT)Target lesions will be treated with preoperative SBRT consisting of biologically effective dose (BED10) of 50.4 - 81.6 Gy delivered in either three fractions or a single fraction.

Timeline

Start date
2021-06-30
Primary completion
2027-06-01
Completion
2027-06-01
First posted
2021-09-08
Last updated
2026-03-05

Locations

7 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT05038124. Inclusion in this directory is not an endorsement.